ovarian cancer - search results

Hernando Lopez-Bertoni, explores the new wave of molecular cancer therapeutics and states the case for learning the mechanisms as a pro, so one can target them as an artist.

Chair of Medical Cell BioPhysics Leon WMM Terstappen highlights why the interrogation of the cancer cells at the single cell level is required to truly understand cancer development.

The NHS have gained a new drug, atezolizumab, which can give 34% protection against lung cancer recurrence or death, post-chemotherapy.

Prof Dangou from the WHO Regional Office for Africa, Congo, speaks about the different kinds of skin cancer:non-melanoma skin cancers and malignant melanoma.

Cancer Centre London’s Keisha Robinson spoke to Open Access Government about cancer treatment in the UK today, in particular, radiotherapy.

Dr Ghazala Aziz-Scott, a specialist in Women’s health at The Marion Gluck Clinic, explores how Premature Ovarian Insufficiency (POI) can affect working women and how they can discuss this problem with their employer.

After a career spanning more than 20 years, a Swansea University Professor’s passion for research is as ‘strong as ever’, as he marks a very notable achievement – the release of his 100th cancer research paper.

Redefining efficiency based on what matters to cancer patients is placed under the spotlight here by All.Can, including identifying opportunities for change.

European Association for Cancer Research’s Chief Executive Officer, Jane Smith, explains why the advancement of cancer research is purely for the public benefit, as well as the importance of collaboration in the field.

Ambitious new plans set out by the Prime Minister today will see around 22,000 fewer people dying from cancer each year by 2033

Cecilia Van Cauwenberghe, Vandana Iyer and Bhargav Rajan from Frost & Sullivan examine of how nanotechnology helps spot early stage cancer

On Target Laboratories' Dr Sumith A. Kularatne shares his research into targeted drugs and notes the difference this treatment makes to cancer patients

New avenues are opening up for treatment of gynaecological cancer, Professor Gunnar Kristensen of Oslo University Hospital explains to Open Access Government Surgery remains an important step in the treatment of ovarian cancer. Two earlier randomised studies revealed the same survival rates for patients who had surgery as the first...

Sumith A Kularatne, Vice President of Research and Development at On Target Laboratories shares the research strides he has made in drug development

Charities have warned changes to the Cancer Drugs Fund are concerning and could leave many new drugs struggling to gain approval… Fifteen cancer charities have written to the Prime Minister expressing their concerns over changes to how innovative cancer drugs are approved for the NHS. The letter outlined fears that many...

Denis Lacombe, John Bean and Mathilde Fenoulhet from the European Organisation for Research and Treatment of Cancer (EORTC) outline how clinical trials play an integral role in tackling cancer…  The European Organisation for Research and Treatment of Cancer (EORTC) is a European, academic, cancer clinical research organisation. A leader in...

Murat Gultekin, Vice-President of the European Society of Gynaecological Oncology (ESGO) highlights the importance of early detection of gynaecological cancers for prevention…  According to World Cancer Report 2014 (IARC), at least one third of cancers are preventable. This is true for gynaecological cancers, especially cervical cancer. However, less than 5%...

The China-United Kingdom Cancer (CUKC) Conference 2015 welcomed approximately 200 experts, including senior medics, scientists and scholars from world leading, international institutions to discuss strategies to fight cancer. The two-day event invited presentations from leading scientists and clinicians on effective cancer prevention, early diagnosis, aggressive treatment and rehabilitation recovery...

Murat Gultekin, Vice-President of the European Society of Gynaecological Oncology (ESGO) highlights the importance of early detection of gynaecological cancers for prevention According to World Cancer Report 2014 (IARC), at least one third of cancers are preventable. This is true for gynaecological cancers, especially cervical cancer. However, less than 5%...

Oslo University Hospital (OUS) is a big hospital formed by the merger of 4 hospitals. The State Hospital, the Norwegian Radium Hospital, Ullevaal Hospital and Aker Hospital. It serves as a local hospital for about 600,000 inhabitants and as a referral centre for about 2.8 million people. As a...